天士力：2025年前三季度净利润约9.84亿元

Group 1 - Company Tianshili reported Q3 2023 revenue of approximately 6.311 billion yuan, a year-on-year decrease of 2.35% [1] - The net profit attributable to shareholders was approximately 984 million yuan, reflecting a year-on-year increase of 16.88% [1] - Basic earnings per share were 0.66 yuan, an increase of 17.86% year-on-year [1] Group 2 - As of the report, Tianshili's market capitalization stands at 23.5 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market's activity compared to the primary market, which is experiencing a fundraising slowdown [2]